You are here
Clinical Trials: Cord Blood
Condition: Viral Infection
Intervention: Biological: HLA-matched VSTs
Sponsors: Baylor College of Medicine; The Methodist Hospital System; Texas Children's Hospital
Not yet recruiting
Intervention: Biological: HLA-matched VSTs
Sponsors: Baylor College of Medicine; The Methodist Hospital System; Texas Children's Hospital
Not yet recruiting
Conditions: Stroke; Umbilical Cord Blood; Erythropoietin; Safety; Treatment Outcome
Interventions: Drug: Umbilical cord blood infusion; Drug: Erythropoietin injection; Drug: Placebo umbilical cord blood infusion; Drug: Placebo erythropoietin injection; Procedure: Active rehabilitation
Sponsors: Bundang CHA Hospital; Korea Evaluation Institute of Industrial Technology
Recruiting
Interventions: Drug: Umbilical cord blood infusion; Drug: Erythropoietin injection; Drug: Placebo umbilical cord blood infusion; Drug: Placebo erythropoietin injection; Procedure: Active rehabilitation
Sponsors: Bundang CHA Hospital; Korea Evaluation Institute of Industrial Technology
Recruiting
Conditions: Alopecia Areata; Alopecia Totalis; Alopecia Universalis
Intervention: Combination Product: Stem Cell Educator therapy combined with minoxidil
Sponsors: Tianhe Stem Cell Biotechnologies Inc.; Yale University; Hackensack Meridian Health
Not yet recruiting
Intervention: Combination Product: Stem Cell Educator therapy combined with minoxidil
Sponsors: Tianhe Stem Cell Biotechnologies Inc.; Yale University; Hackensack Meridian Health
Not yet recruiting
Condition: Type 1 Diabetes
Intervention: Combination Product: Stem Cell Educator therapy
Sponsors: Tianhe Stem Cell Biotechnologies Inc.; Hackensack Meridian Health
Not yet recruiting
Intervention: Combination Product: Stem Cell Educator therapy
Sponsors: Tianhe Stem Cell Biotechnologies Inc.; Hackensack Meridian Health
Not yet recruiting
Condition: Bronchopulmonary Dysplasia
Interventions: Biological: PNEUMOSTEM®; Biological: normal saline
Sponsor: Medipost Co Ltd.
Not yet recruiting
Interventions: Biological: PNEUMOSTEM®; Biological: normal saline
Sponsor: Medipost Co Ltd.
Not yet recruiting
Condition: Spinal Cord Injuries
Interventions: Biological: Umbilical Cord Blood Mononuclear Cell; Drug: Lithium Carbonate; Other: Placebo; Other: Locomotor Training
Sponsors: StemCyte, Inc.; Amarex Clinical Research
Not yet recruiting
Interventions: Biological: Umbilical Cord Blood Mononuclear Cell; Drug: Lithium Carbonate; Other: Placebo; Other: Locomotor Training
Sponsors: StemCyte, Inc.; Amarex Clinical Research
Not yet recruiting
Condition: Acute Myeloid Leukemia
Intervention: Biological: Unrelated cord blood
Sponsors: Ruijin Hospital; Navy General Hospital of PLA; Beijing Jishuitan Hospital; The Affiliated Hospital of Xuzhou Medical University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Luoyang Central Hospital; People's Hospital of Zhengzhou University; Dongguan People's Hospital; The First Affiliated Hospital of Xiamen University; Taian City Central Hospital; Qilu Hospital of Shandong University (Qingdao)
Recruiting
Intervention: Biological: Unrelated cord blood
Sponsors: Ruijin Hospital; Navy General Hospital of PLA; Beijing Jishuitan Hospital; The Affiliated Hospital of Xuzhou Medical University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Luoyang Central Hospital; People's Hospital of Zhengzhou University; Dongguan People's Hospital; The First Affiliated Hospital of Xiamen University; Taian City Central Hospital; Qilu Hospital of Shandong University (Qingdao)
Recruiting
Conditions: High Risk Hematologic Malignancy; Cord Blood Transplant
Intervention: Biological: Transplant with an expanded ECT-001 cord blood
Sponsors: Ciusss de L'Est de l'Île de Montréal; Stem Cell Network (SCN); Hopital de l'Enfant-Jesus; Centre Universitaire de Santé McGill; ExCellThera inc.
Not yet recruiting
Intervention: Biological: Transplant with an expanded ECT-001 cord blood
Sponsors: Ciusss de L'Est de l'Île de Montréal; Stem Cell Network (SCN); Hopital de l'Enfant-Jesus; Centre Universitaire de Santé McGill; ExCellThera inc.
Not yet recruiting
Conditions: Hematological Malignancy; Acute Leukemia in Remission; Acute Lymphoblastic Leukemia in Remission; Myelodysplastic Syndromes; Non-Hodgkin Lymphoma; Hodgkin Lymphoma
Interventions: Biological: Cord blood stem cells; Drug: Valproic Acid; Drug: Fludarabine; Drug: cytoxan; Drug: Thiotepa; Biological: TBI
Sponsor: Alla Keyzner
Recruiting
Interventions: Biological: Cord blood stem cells; Drug: Valproic Acid; Drug: Fludarabine; Drug: cytoxan; Drug: Thiotepa; Biological: TBI
Sponsor: Alla Keyzner
Recruiting
Conditions: Diabetes Mellitus, Type 1; Immunologic Deficiency Syndromes
Intervention: Procedure: Sequential transplantation
Sponsor: Children's Hospital of Fudan University
Not yet recruiting
Intervention: Procedure: Sequential transplantation
Sponsor: Children's Hospital of Fudan University
Not yet recruiting
